| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e741af60b7abb8b86e07a34ae63501db |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-708
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-343 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-708
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-343 |
| filingDate |
2016-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0749a7747410c349593f96ac92b30aa3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_faffe2bbc18b57c57bd01c05e47c2419 |
| publicationDate |
2017-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-106668057-A |
| titleOfInvention |
Pharmaceutical composition for resisting influenza virus infection |
| abstract |
The invention discloses a medicine for resisting influenza virus, consisting of the active components: Hydrangenone and N2-methylguanosine. The medicine adopts combined application of the Hydrangenone and N2-methylguanosine, and shown by experimental results, the Hydrangenone and N2-methylguanosine have good effects in resisting influenza virus. |
| priorityDate |
2016-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |